(Reuters) - Second-quarter profit increased to $517 million, or 34 cents per share, from $237 million, or 16 cents per share, a year earlier.
Excluding special items, the drug maker earned 41 cents per share. Analysts on average expected 35 cents a share, according to Reuters Estimates.
Read more at Reuters.com Business News
Excluding special items, the drug maker earned 41 cents per share. Analysts on average expected 35 cents a share, according to Reuters Estimates.
Read more at Reuters.com Business News
No comments:
Post a Comment